128 related articles for article (PubMed ID: 7742396)
21. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
[TBL] [Abstract][Full Text] [Related]
22. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
23. The significance of cervical cytologic dysplasia.
Jordan SW; Smith NL; Dike LS
Acta Cytol; 1981; 25(3):237-44. PubMed ID: 6942614
[TBL] [Abstract][Full Text] [Related]
24. Relation of dysplasia and carcinoma of the uterine cervix to age at onset of sexual life and number of coital partners.
Berget A
Dan Med Bull; 1978 Aug; 25(4):172-6. PubMed ID: 688775
[No Abstract] [Full Text] [Related]
25. Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions.
Liu J; Rose B; Huang X; Liao G; Carter J; Wu X; Thompson C
Gynecol Oncol; 2004 Sep; 94(3):803-10. PubMed ID: 15350376
[TBL] [Abstract][Full Text] [Related]
26. Cervix cancer precursors in young offspring of low-income families.
Nealon NA; Christopherson WM
Obstet Gynecol; 1979 Aug; 54(2):135-9. PubMed ID: 460744
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria.
Ogunbowale T; Lawoyin TO
Aust J Rural Health; 2008 Dec; 16(6):338-42. PubMed ID: 19032205
[TBL] [Abstract][Full Text] [Related]
28. [Studies on the prevalence and incidence rate of epithelial neoplasia of the uterine cervix by mass survey using mobile units].
Hando T; Sugimori H; Higashiiwai H; Kuroshima Y; Nishiya I; Sugimoto O; Noda K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2287-90. PubMed ID: 4078419
[TBL] [Abstract][Full Text] [Related]
29. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
[TBL] [Abstract][Full Text] [Related]
30. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
32. [Cancer of the cervix, papillomavirus, contraception and tobacco].
Thiry L; Vokaer R; Detremmerie O; De Schepper N; Herzog A; Bollen A
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):477-86. PubMed ID: 8228010
[TBL] [Abstract][Full Text] [Related]
33. [Effectiveness of cervical screening - expectation and reality].
Kostova P; Zlatkov V
Akush Ginekol (Sofiia); 2000; 39(3):23-4. PubMed ID: 11187989
[TBL] [Abstract][Full Text] [Related]
34. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
35. Cervical dysplasia in HIV infected women in Maiduguri, Nigeria.
Chama CM; Nggada H; Gashau W
J Obstet Gynaecol; 2005 Apr; 25(3):286-8. PubMed ID: 16147738
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a hospital based cytology screening programme for reduction in life time risk of cervical cancer.
Agarwal SS; Murthy NS; Sharma S; Sharma KC; Das DK
Neoplasma; 1995; 42(2):93-6. PubMed ID: 7617084
[TBL] [Abstract][Full Text] [Related]
37. Biological behaviour of moderate dysplasia--a prospective study.
Murthy NS; Sardana S; Narang N; Agarwal SS; Sharma S; Das DK
Indian J Cancer; 1996 Mar; 33(1):24-30. PubMed ID: 9063015
[TBL] [Abstract][Full Text] [Related]
38. Detection of HSV-2 antigen in carcinoma cervix and premalignant conditions by immuno-cytochemistry.
Pandit AA; Khilnani PH; Powar H; Bhave GG; Chadda NO
J Postgrad Med; 1990 Oct; 36(4):185-90. PubMed ID: 2132242
[TBL] [Abstract][Full Text] [Related]
39. [The cervix and hormonal contraception].
Gorins A
Contracept Fertil Sex (Paris); 1985; 13(7-8):895-9. PubMed ID: 12340276
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of cervical carcinoma in Brunei Darussalam. Analysis of data on 27,208 women screened with cytologic examinations.
Affandi MZ; Dun T; Mantuano V; Sidhu R; Lumplugh C; Telisinghe PU
Acta Cytol; 1993; 37(2):175-80. PubMed ID: 8465637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
